A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AP / antiplatelet

[Related PubMed/MEDLINE]
Total Number of Papers: 102
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AP  (>> Co-occurring Abbreviation)
Long Form:   antiplatelet
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Antiplatelet Medications Are Associated With Bleeding and Decompensation Events Among Patients With Cirrhosis. AC, aHR, CI, NSAID
2021 Antithrombotic choice in blunt cerebrovascular injuries: Experience at a tertiary trauma center, systematic review, and meta-analysis. AC, BCVIs, OR
2021 Antithrombotics in Patients With a Femoral Neck Fracture: Evaluating Daily Practice in an Observational Cohort Study. VKA
2021 Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. AF, aHR, CI, CRNM, HR, ICH, NOACs, VKAs
2021 Clinical characteristics and outcomes of chronic subdural hematoma in patients with a history of antiplatelet therapy. CSDH
2021 Drug-drug Interactions with Warfarin: A Systematic Review and Meta-analysis. CIs, GI, IPA, OR, PPIs
2021 Intravesical onabotulinumtoxinA injections in patients on antiplatelet and anticoagulation therapy. AC, BoNT-A
2021 Limited benefit of systematic head CT for mild traumatic brain injury in patients under antithrombotic therapy. AC, DOAC, IH, mTBI
2021 Recent evidence for anatomic endoscopic enucleation of the prostate (AEEP) in patients with benign prostatic obstruction on antiplatelet or anticoagulant therapy. AC, AEEP, BPH, LUTS
10  2021 Risk Factors for Severe Bleeding Complications in Vitreoretinal Surgery and the Role of Antiplatelet or Anticoagulant Agents. AC
11  2021 Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy. AC, DBE
12  2021 Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry. SE
13  2021 Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke. AIS, DAPT, IVT, sICH
14  2021 The Effect of Anticoagulation and Antiplatelet Use in Trauma Patients on Mortality and Length of Stay. AAT, AC, LOS
15  2020 Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. APS, CI, HR, INR, MD, RCTs, RR, SD
16  2020 Effect of antiplatelet agent number, types, and pre-endoscopic management on post-polypectomy bleeding: validation of endoscopy guidelines. aOR, DAPT, PPB, TAPT
17  2020 Effect of direct-acting oral anticoagulants (DOACs) on bleeding and blood product usage in cardiac surgery compared to warfarin and controls. DOAC, DOACs
18  2020 Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion. AF, LASO, OAC
19  2020 Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression. AC, CSS
20  2020 Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China. ACS, AMPs
21  2020 Mortality in relation to presence and type of oral antithrombotic agent among adult trauma patients: a single-center retrospective cohort study. AC, DOAC, ICU, LOS
22  2020 No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib. AC, CLL, iNHL
23  2020 Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation. aHR, OAC
24  2020 Real-World Experience of Holmium Laser Enucleation of the Prostate with Patients on Anticoagulation Therapy. AC, DOACs, ED, HoLEP
25  2020 Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation. AC, NOACs, NVAF
26  2020 Risks and complications of robot-assisted radical prostatectomy (RARP) in patients receiving antiplatelet and/or anticoagulant therapy: a retrospective cohort study in a single institute. AC, RARP
27  2020 Safety of Surgery in benign Prostatic Hyperplasia Patients on Antiplatelet or Anticoagulant Therapy: A Systematic Review and Meta-Analysis. AC, BPH, CI, MD, OR, TURP
28  2020 Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience. AF, CI, NOACs, OAC, OR
29  2019 A Review of Antithrombotic Treatment in Critical Limb Ischemia After Endovascular Intervention. CLI, DAPT, MAPT, TLR
30  2019 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate in Patients Under Either Anticoagulation or Antiplatelet Therapy. AC, B-TUEP, HoLEP, HS, IPSS
31  2019 Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) Registry. AC, AT, ELECTRa, TLE
32  2019 Effect of preoperative antiplatelet or anticoagulation therapy on hemorrhagic complications in patients with traumatic brain injury undergoing craniotomy or craniectomy. AC, TBI
33  2019 Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. CI, HR, OAC
34  2019 Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. GARFIELD-AF, NOACs, VKAs
35  2019 Spinal cord infarction presenting as Brown-Sequard syndrome from spontaneous vertebral artery dissection: a case report and literature review. AC, MRI, SCI, VAD, VISTA
36  2019 Surveillance and Management of Troponin Elevation after Vascular Surgery. ---
37  2018 Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. AC, NOACS
38  2018 Does Antithrombotic Drug Use Mandate Trauma Team Activation in Awake Geriatric Patients with Intracranial Hemorrhage? AC, ICH, TTA
39  2018 In vitro effects of a kaolin-coated hemostatic dressing on anticoagulated blood. CFT, CT, DTI, KCM, UH, VKA, Xa
40  2018 Long-term follow-up of antithrombotic management patterns in acute coronary syndrome patients. AC, ACS, AMPs, CV, NSTEMI, STEMI, UA
41  2018 Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. AC, ITP
42  2018 Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies. AC, OR, S-ICD
43  2018 Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. ACs, AF, CHF, CKD, SE, VascD
44  2018 Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry. AF, NOACs, VKAs
45  2018 Video-assisted mediastinoscopy is safe in patients taking antiplatelet or anticoagulant therapy. VAM
46  2017 Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage. ICH, VKA
47  2017 Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study. AF, AT, GPs, OACs
48  2017 Assessment of three point-of-care platelet function assays in adult trauma patients. AUC, AUC, AUC, ICH
49  2017 Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry. ACs, AF
50  2017 Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke. AIS, ICH, MA, TEG
51  2017 Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. AC, AT, NVAF
52  2017 Holmium Laser Enucleation of the Prostate in Patients Requiring Anticoagulation. AC, BPH, DOACs, HoLEP, LUTS
53  2017 Impact of the Number of Anti-Thrombosis Agents in Hemodialysis Patients: BOREAS-HD2 Study. HD, WF
54  2017 Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices. ASA, PA, VADs
55  2017 Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series. ALOS, ASA, TURBT
56  2017 Resumption of antiplatelet therapy in patients with primary intracranial hemorrhage-benefits and risks: A meta-analysis of cohort studies. CI, ICH, RR
57  2017 Safety and feasibility study of holmium laser enucleation of the prostate (HOLEP) on patients receiving dual antiplatelet therapy (DAPT). BPH, DAPT, HoLEP, IPSS, QoL, RUV
58  2017 Ultra-early hematoma growth in antithrombotic pretreated patients with intracerebral hemorrhage. CT, ICH, uHG, VKA
59  2016 Anticoagulation versus antiplatelet or no therapy in patients undergoing bioprosthetic valve implantation: a systematic review and meta-analysis. OR, VKA
60  2016 Antiplatelet and oral anticoagulant therapies in chronic hemodialysis patients: prescribing practices and bleeding risk. AC
61  2016 Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. DFS, DMR, TNBC
62  2016 Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients? AIS, CI, HT, IVT, OR
63  2016 Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. AC, AF, GARFIELD-AF, NOACs, VKA
64  2016 Hemorrhagic and Thromboembolic Complications after Hepato-Biliary-Pancreatic Surgery in Patients Receiving Antithrombotic Therapy. AC, HBP
65  2016 Holmium Laser Enucleation of the Prostate in Patients Requiring Anticoagulation. AC, BPH, HoLEP
66  2016 Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy. AC, OR, RAPN
67  2016 The Effect of Anticoagulation on Bleeding-related Complications Following Ureteroscopy. AC, URS
68  2016 Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. NVAF, SE
69  2015 Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice. AF, CIs, OAC, OR
70  2015 Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy. ET, NS, TCE
71  2015 Participation in the Vascular Quality Initiative is associated with improved perioperative medication use, which is associated with longer patient survival. CI, MM, VQI
72  2015 Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience. AC, TURP
73  2015 Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome. ICH, NIHSS, OR, THEPI, TIMS-China
74  2015 Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative. CI, MI, OR
75  2014 Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. AF, OAC
76  2014 Heterogeneous practice patterns regarding antiplatelet medications for neuroendovascular stenting in the USA: a multicenter survey. ASA, PEDs, POC, REDCap
77  2014 Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care. ASA, DAT, GI, PPIs
78  2014 Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. CI
79  2014 Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients. sICH, TIMS-China
80  2013 Does anticoagulation promote mural hematoma growth or delayed occlusion in spontaneous cervical artery dissections?. AC, CAD, DWI, MRI
81  2012 Anticoagulation management around percutaneous bedside procedures: is adjustment required? AC, PDT, PEG
82  2012 Detection of atrial fibrillation after cryptogenic stroke. AF, OAC, PAF
83  2012 Meta-analysis of bleeding complications associated with cardiac rhythm device implantation. AC, HBS
84  2011 A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs. AC
85  2011 Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program. AC, HM, LMWH
86  2011 Long-term effects of antiplatelet drugs on aneurysm occlusion after endovascular treatment. ASA, EVT
87  2011 Percutaneous endoscopic gastrostomy complication rates and compliance with the American Society for Gastrointestinal Endoscopy guidelines for the management of antithrombotic therapy. AC, ASGE, PEG
88  2011 Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis. ER, IVT, MCA, sICH
89  2011 Reported antiplatelet use influences long-term outcome independently in deep intracerebral hemorrhage. ICH, OR
90  2011 Use of antiplatelets. A survey of secondary prevention of ischemic stroke with intracranial hemorrhage history in Chinese patients. CI, ICH, OR
91  2010 A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. AF, ATs, OAC
92  2010 Antiplatelet agents are risk factors for cerebellar hemorrhage in patients with primary intracerebral hemorrhage. ATs, CH, ICH
93  2010 Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke? rt-PA
94  2010 Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome? AC, FFP, ICH, IQR, IVE
95  2009 Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. OAC
96  2008 Internal carotid artery stenting for blunt carotid artery injuries with an associated pseudoaneurysm. AC, BCI, PA
97  2008 Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. sICH
98  2007 Prior antiplatelet use and infarct volume in ischemic stroke. DWI
99  2006 Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. CT, ED, ICH, MRS, OA
100  2002 Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. AC, GCS